| Ticker |
BLCM
|
| CIK | 0001358403 |
| SIC | 2834 |
| Sector | Manufacturing |
| Industry Category | Pharmaceutical Products |
| Industry Group | Pharmaceutical Preparations |
| Address | 3730 KIRBY DRIVE, SUITE 1200, HOUSTON, TX, 77098 |
| Website | bellicum.com |
| Phone | (832) 384-1100 |
| CEO | Richard A. Fair |
| Employees | 7 |
Our team will help you customize a package that meets the needs of your business.
Request a Consultation|
Standardized FinancialsdocsIntrinio provides professional-grade historical financial data. This data is standardized, cleansed and verified to ensure the highest quality data sourced directly from the XBRL financial statements. The primary purpose of standardized financials are to facilitate comparability across a single company’s fundamentals and across all companies fundamentals. For example, it is possible to compare total revenues between two companies as of a certain point in time, or within a single company across multiple time periods. This is not possible using the as reported financial statements because of the inherent complexity of reporting standards. Below is a preview of several data points from each financial statement, as well as a sample of our many calculated metrics: |
|||||||||||||||||||||
|
Income Statement
|
Balance Sheet
|
||||||||||||||||||||
|
Cash Flow Statement
|
Calculations
|
||||||||||||||||||||
|
Latest NewsdocsIntrinio provides up-to-date news articles on every US company from various sources. Here are several examples: |
CAR T-cell Therapy Clinical Trial Pipeline Insights Featuring 250+ Companies | DelveInsightDelveInsight’ s CAR T-cell Therapy pipeline report depicts a robust space with 250+ active players working to develop 500+ pipeline therapies.. LAS VEGAS, CALIFORNIA, UNITED STATES OF AMERICA, March 22, 2024/ EINPresswire.com/-- DelveInsight’ s CAR T-cell Therapy Competitive Landscape report provides comprehensive global coverage of available, marketed, and... Small Cell Lung Cancer Pipeline 2024: FDA Approvals, Therapies, Clinical Trials and Key Companies by DelveInsightSmall Cell Lung Cancer companies are Akeso, Ascentage Pharma, BioNTech, Qilu Pharmaceutical, Amgen, BeiGene, Genentech, AbbVie, Amgen, Daiichi Sankyo,& others.. ALBANY, NEW YORK, UNITED STATES, March 22, 2024/ EINPresswire.com/-- As per DelveInsight’ s assessment, globally, Small Cell Lung Cancer pipeline constitutes 100+ key companies continuously working towards... |
